Showing results (601-610 of 5,983) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|April 14, 2007
Uncommon tumors and exceptional therapies: paradox or paradigm?Fadi Braiteh, Razelle KurzrockMolecular Cancer Therapeutics|April 14, 2007
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agentsWalter M StadlerMolecular Cancer Therapeutics|April 14, 2007
Levels of p27(kip1) determine Aplidin sensitivityVictoria Moneo, Beatriz G Serelde, Juan F M Leal, et al.Molecular Cancer Therapeutics|April 14, 2007
Identification of a novel inhibitor of urokinase-type plasminogen activatorMing Zhu, Vijay M Gokhale, Lajos Szabo, et al.Molecular Cancer Therapeutics|April 14, 2007
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, et al.Molecular Cancer Therapeutics|April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cellsSangkil Nam, Ann Williams, Adina Vultur, et al.Molecular Cancer Therapeutics|April 14, 2007
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activationYasuhisa Oida, Began Gopalan, Ryo Miyahara, et al.Molecular Cancer Therapeutics|July 11, 2007
Regulation of mitosis via mitotic kinases: new opportunities for cancer managementTravis L Schmit, Nihal AhmadMolecular Cancer Therapeutics|July 11, 2007
Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancerDennis Hoffmann, Wibke Bayer, Thomas Grunwald, et al.Molecular Cancer Therapeutics|July 11, 2007
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cellsEllen Weisberg, Andrew L Kung, Renee D Wright, et al.Pageof 599